Pharmaceutical | Tokio X'press - Part 83

💊武田注意到Shire plc关于修订提案和PUSU截止日期延长至2018年5月8日的声明

04/25/18 WednesdayBy Tokio X'press Drugs, Pharmaceutical Takeda

💊Otsuka的JYNARQUE™被美国FDA批准为缓慢发展为常染色体显性多囊肾病（ADPKD）风险的成人缓慢肾功能下降的首选治疗方法

04/25/18 WednesdayBy Tokio X'press FDA, Pharmaceutical otsuka

💊Takeda Statement Regarding Improved Proposal for Shire plc

04/22/18 SundayBy Tokio X'press Drugs, Pharmaceutical Takeda

💊关于Shire plc的武田声明

04/20/18 FridayBy Tokio X'press Pharmaceutical Takeda

💊FDA & DRUG TODAY

04/17/18 TuesdayBy Tokio X'press Drugs, Pharmaceutical ONO